Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBER | SRZN | SXTC | ||
| Company | Ibere Pharmaceuticals Cl A | Consonance-Hfw Acq Corp | China Sxt Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 10.18 | 22.05 | 1.5200 | ||
| High | 10.18 | 22.64 | 1.6400 | ||
| Low | 10.18 | 20.95 | 1.5200 | ||
| Latest | 10.18 | 22.56 | 1.6200 | ||
| Change | -0.03 | +0.95 | +0.1700 | ||
| % Change | -0.29% | +4.40% | +11.72% | ||
| Volume | 44,400 | 103,638 | 51,466 | ||
| 20-Day Average Volume | 61,365 | 113,183 | 210,229 | ||
| Previous Close | 10.21 | 21.62 | 1.4500 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.17 | 17.99 | 1.4145 | ||
| 20-Day Raw Stochastic | 5.79% | 72.44% | 66.67% | ||
| 20-Day Relative Strength | 62.60 | 66.61 | 58.83 | ||
| Weighted Alpha | +5.10 | +134.83 | -48.29 | ||
| Today's Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 64% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/17/23 | -2.35% since 12/09/25 | +19.12% since 12/09/25 | ||
| Low | 10.17 on 02/21/23 | 20.61 on 12/15/25 | 1.3500 on 12/11/25 | ||
| High | 10.21 on 02/28/23 | 24.94 on 12/12/25 | 1.7800 on 12/15/25 | ||
| 1-Month | |||||
| %Chg | +0.20% since 02/01/23 | +66.26% since 11/14/25 | +22.73% since 11/14/25 | ||
| Low | 10.15 on 02/06/23 | 12.52 on 11/17/25 | 1.3000 on 11/21/25 | ||
| High | 10.75 on 02/06/23 | 24.94 on 12/12/25 | 1.7800 on 12/15/25 | ||
| 3-Month | |||||
| %Chg | +1.50% since 11/30/22 | +86.68% since 09/16/25 | -13.37% since 09/16/25 | ||
| Low | 10.03 on 12/02/22 | 11.35 on 09/17/25 | 1.2000 on 10/27/25 | ||
| High | 10.75 on 02/06/23 | 24.94 on 12/12/25 | 2.0800 on 09/19/25 | ||
| 6-Month | |||||
| %Chg | +3.25% since 09/01/22 | +126.21% since 06/16/25 | -6.36% since 06/16/25 | ||
| Low | 9.87 on 09/02/22 | 8.00 on 06/26/25 | 1.1300 on 09/05/25 | ||
| High | 10.75 on 02/06/23 | 24.94 on 12/12/25 | 2.0800 on 09/19/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 175,605 | 185,271 | 168,239 | ||
| Shares Outstanding, K | 17,250 | 8,571 | 116,027 | ||
| Annual Sales | 0 | 10,660,000 | 1,740,000 | ||
| Annual Net Income | 1,560,000 | -63,560,000 | -3,300,000 | ||
| Last Quarter Sales | 0 | 980,000 | N/A | ||
| Last Quarter Net Income | 789,819 | -71,640,000 | N/A | ||
| 60-Month Beta | 0.00 | 0.62 | 1.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.06 on 11/14/22 | -3.61 on 11/07/25 | N/A | ||
| Latest Earnings Date | 03/06/23 | 03/30/26 | 01/01/70 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||